Introduction
Opioid medications are commonly prescribed to manage acute and chronic pain. However, their use carries significant risks, including addiction, overdose, and death. To mitigate these dangers, the Centers for Disease Control and Prevention (CDC) released updated guidelines in 2022, emphasizing cautious and informed prescribing practices. This article provides a comprehensive overview of these guidelines to assist patients in understanding and navigating opioid therapy.
Determining the Need for Opioids
Before initiating opioid therapy, healthcare providers should assess whether non-opioid treatments can effectively manage the patient’s pain. The CDC recommends:
- Maximizing Nonpharmacologic and Nonopioid Therapies: Utilize treatments such as physical therapy, cognitive-behavioral therapy, and non-opioid medications like acetaminophen or NSAIDs.
- Considering Opioids Only When Necessary: Opioids should be prescribed only when the expected benefits for pain and function outweigh the risks.
- Prescribe Immediate-Release Opioids: These are preferred over extended-release or long-acting formulations for acute, subacute, or chronic pain.
- Start with the Lowest Effective Dose: For opioid-naïve patients, initiate therapy with the lowest effective dose to minimize risks.
- Avoid High Dosages: Dosages exceeding 50 morphine milligram equivalents (MME) per day should be prescribed with caution, and those above 90 MME/day should be carefully justified or avoided.
- Acute Pain: Prescribe no more than the quantity needed for the expected duration of severe pain.
- Chronic Pain: Regularly evaluate the benefits and risks of continued opioid therapy, with assessments within 1–4 weeks of starting or escalating the dose, and at least every three months thereafter.
- Evaluate Risk Factors: Before starting and periodically during opioid therapy, assess the patient’s risk for opioid-related harms.
- Offer Naloxone: Provide naloxone to patients at increased risk for overdose, such as those on high-dose opioids or with a history of substance use disorder.
- Review Prescription History: Utilize state prescription drug monitoring programs to identify patients receiving high doses or combinations of opioids that increase overdose risk.
- Avoid Concurrent Use with Benzodiazepines: Co-prescribing opioids and benzodiazepines should be avoided whenever possible due to the heightened risk of respiratory depression.
- Monitor for Drug Interactions: Be cautious of interactions with other central nervous system depressants, such as gabapentinoids, which can potentiate opioid-induced respiratory depression.
- Gradual Tapering: Implement a slow taper to minimize withdrawal symptoms, often reducing the daily dosage by 10% per month.
- Optimize Other Therapies: Enhance non-opioid treatments to manage pain effectively during the tapering process.
- Establish Treatment Goals: Collaboratively set realistic goals for pain and function before initiating opioid therapy.
- Regular Follow-Up: Schedule periodic evaluations to assess the effectiveness of therapy and make necessary adjustments.
- Non-Opioid Therapies: Preferred for managing acute and chronic pain before considering opioids.
- Immediate-Release Opioids: Recommended over extended-release formulations for acute pain.
- Dosage Caution: Prescribe the lowest effective dose, avoiding dosages above 50 MME/day without careful justification.
- Co-Prescribing Risks: Avoid concurrent use of opioids and benzodiazepines due to increased risk of respiratory depression.
- Tapering Strategy: Gradual reduction of opioid dosage by 10% per month to minimize withdrawal symptoms.
- Centers for Disease Control and Prevention, 2022 Clinical Practice Guideline for Prescribing Opioids for Pain. (cdc.gov)
- American Academy of Family Physicians, Affirmation of Value, June 2023. (aafp.org)
- U.S. Food and Drug Administration, FDA Requiring Opioid Pain Medicine Manufacturers to Update Prescribing Information Regarding Long-Term Use. (fda.gov)
- Centers for Disease Control and Prevention, Guideline Recommendations and Guiding Principles. (cdc.gov)
- Centers for Disease Control and Prevention, Overdose Prevention: Opioid Prescribing Guidelines. (in.gov)
Selecting Opioids and Determining Dosages
If opioid therapy is deemed appropriate, the following guidelines should be followed:
Duration of Opioid Therapy
The length of opioid therapy should be carefully considered:
Assessing Risks and Addressing Potential Harms
To minimize potential harms associated with opioid use:
Co-Prescribing with Other Medications
Certain combinations of medications can increase the risk of adverse effects:
Tapering and Discontinuing Opioids
If opioid therapy is no longer beneficial or necessary:
Patient and Provider Communication
Open communication between patients and healthcare providers is crucial:
Conclusion
Understanding opioid prescribing guidelines empowers patients to make informed decisions about their pain management. By adhering to these guidelines, patients and healthcare providers can work together to ensure safe and effective treatment, minimizing the risks associated with opioid use.